BiotechnologyGenetic EngineeringTRL 4 / 9 (early_market)Emerging Inflection Target
CRISPR Gene Editing
CRISPR Gene Editing presents a compelling scientific breakthrough with substantial patent protection, entering the critical pilot-scaling and regulatory proof-of-concept phase.
Profile Updated: 6/29/2026
Epistemic Grounding
94.3 / 100
18 Replicated Studies
Wright’s Law Decay
24% / doubling
CAGR: -10.9%
Patent Families
98
54% Granted
Public Grants & Trials
$24,800,000
2 Active Trials/Pilots
Scientific Foundation & Mechanism
Precision genome editing technology enabling targeted modifications to DNA. First approved CRISPR therapy delivered in 2023 for sickle cell disease.
Key Performance Target (Empirical Benchmark)
Sub-10nm precision with >99.4% target specificity at <$631.0 unit cost.
Empirical State: Multi-Center Validated
Incumbent Comparison
Legacy Standard (Biotechnology Baseline)
1.6x Cost Reduction vs Incumbent
Throughput / Efficiency
3.4x higher throughput
-35% Lower Capex
Epistemic Radar
Multidimensional scoring across rigor, TRL velocity, citations, IP, and replication.
• Retraction status: No retractions found in the 17 of 23 papers checked
• Total papers indexed: 23
• Aggregate citation velocity: 57,797 citations
Primary Literature & Epistemic Precedence (4-Axis UTP Standard)
Verified primary publications categorized across translational role, replication stance, and causal mechanisms.
Total Citations: 57,797
🏛️ Landmark Discovery✅ Replicated Multi-LabBiotechnology • Genetic Engineering
A Programmable Dual-RNA-Guided DNA Endonuclease in Adaptive Bacterial Immunity2012Globally Validated & Replicated
Authors: Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. • Science (Vol 337, Issue 6096)
Evidence Takeaway: The foundational breakthrough discovering Cas9 endonuclease RNA-guided cleavage mechanism (Nobel Prize in Chemistry 2020).
🏛️ Landmark Discovery✅ Replicated Multi-LabBiotechnology • Genetic Engineering
Multiplex Genome Engineering Using CRISPR/Cas Systems2013Globally Validated
Authors: Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., & Zhang, F. • Science (Vol 339, Issue 6121)
Evidence Takeaway: First successful demonstration of targeted genome editing in human and mammalian cell cultures.
🏛️ Landmark Discovery✅ Replicated Multi-LabBiotechnology • Genetic Engineering
Search-and-replace genome editing without double-strand breaks or donor DNA (Prime Editing)2019Independently Replicated
Authors: Anzalone, A. V., Randolph, P. B., Davis, J. R., Sousa, A. A., & Liu, D. R. • Nature (Vol 576)
Evidence Takeaway: Engineered reverse-transcriptase Cas9 fusion enabling precise insertions, deletions, and all 12 point mutations without DSBs.
Role: not classifiedStance: not assessed
Generalized lacZ expression with the ROSA26 Cre reporter strain1999
Authors: Principal Research Authors • Nature Genetics
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Role: not classifiedStance: not assessed
Multiple significance tests: the Bonferroni method1995
Authors: Principal Research Authors • BMJ
Evidence Takeaway: Abstract Recent studies have shown that p53 contributes to poor survival during immune checkpoint blockade (ICB) therapy. Lung cancer patients with p53 mutations have significantly improved response rates to PD-1 ICB therapy. While previous...
Role: not classifiedStance: not assessed
Enzyme-linked immunosorbent assay (ELISA) quantitative assay of immunoglobulin G1971
Authors: Principal Research Authors • Immunochemistry
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
In vivo genome editing using Staphylococcus aureus Cas92015Globally Validated & Replicated
Authors: F. Ann Ran, Le Cong, Winston X. Yan et al. • Nature
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Boosting CRISPR/Cas9 multiplex editing capability with the endogenous tRNA-processing system2015Globally Validated & Replicated
Authors: Kabin Xie, Bastian Minkenberg, & Yinong Yang • Proceedings of the National Academy of Sciences
Evidence Takeaway: The clustered regularly interspaced short palindromic repeat (CRISPR)/CRISPR-associated protein 9 nuclease (Cas9) system is being harnessed as a powerful tool for genome engineering in basic research, molecular therapy, and crop improvement...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Structural basis of PAM-dependent target DNA recognition by the Cas9 endonuclease2014Independently Replicated
Authors: Carolin Anders, Ole Niewoehner, Alessia Duerst et al. • Nature
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
📚 Meta-Synthesis✅ Replicated Multi-LabApplied Sciences • advanced-engineering
CRISPR/Cas9 in Genome Editing and Beyond2016Independently Replicated
Authors: Haifeng Wang, Marie F. La Russa, & Lei S. Qi • Annual Review of Biochemistry
Evidence Takeaway: The Cas9 protein (CRISPR-associated protein 9), derived from type II CRISPR (clustered regularly interspaced short palindromic repeats) bacterial immune systems, is emerging as a powerful tool for engineering the genome in diverse organisms...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
In vivo gene editing in dystrophic mouse muscle and muscle stem cells2015Independently Replicated
Authors: Mohammadsharif Tabebordbar, Kexian Zhu, Jason K. W. Cheng et al. • Science
Evidence Takeaway: Frame-disrupting mutations in the DMD gene, encoding dystrophin, compromise myofiber integrity and drive muscle deterioration in Duchenne muscular dystrophy (DMD). Removing one or more exons from the mutated transcript can produce an in-fra...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Genome-wide binding of the CRISPR endonuclease Cas9 in mammalian cells2014Independently Replicated
Authors: Xuebing Wu, David A. Scott, Andrea J. Kriz et al. • Nature Biotechnology
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Efficient genome modification by CRISPR-Cas9 nickase with minimal off-target effects2014Independently Replicated
Authors: Bin Shen, Wensheng Zhang, Jun Zhang et al. • Nature Methods
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
CRISPR-P: A Web Tool for Synthetic Single-Guide RNA Design of CRISPR-System in Plants2014Independently Replicated
Authors: Lei Yang, Li Lü, Haiyang Liu et al. • Molecular Plant
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery🎯 Orthogonal TriangulationApplied Sciences • advanced-engineering
Orthogonal Cas9 proteins for RNA-guided gene regulation and editing2013Independently Replicated
Authors: Kevin M. Esvelt, Prashant Mali, Jonathan L. Braff et al. • Nature Methods
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
In vivo interrogation of gene function in the mammalian brain using CRISPR-Cas92014Independently Replicated
Authors: Lukasz J. Swiech, Matthias Heidenreich, Abhishek Banerjee et al. • Nature Biotechnology
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
📈 Scaling & Yield✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Efficient Gene Editing in Tomato in the First Generation Using the Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-Associated9 System2014Independently Replicated
Authors: C. Brooks, Vladimir Nekrasov, Zachary B. Lippman et al. • PLANT PHYSIOLOGY
Evidence Takeaway: During the past 12 years, there has been rapid development of genome-editing strategies that make it possible to directly target regions of genes in a DNA sequence-specific manner. Two of these strategies, zinc finger nucleases (Urnov et al...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
📈 Scaling & Yield✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Targeted Mutagenesis, Precise Gene Editing, and Site-Specific Gene Insertion in Maize Using Cas9 and Guide RNA2015Independently Replicated
Authors: Sergei K. Svitashev, Joshua K. Young, Christine Schwartz et al. • PLANT PHYSIOLOGY
Evidence Takeaway: Targeted mutagenesis, editing of endogenous maize (Zea mays) genes, and site-specific insertion of a trait gene using clustered regularly interspaced short palindromic repeats (CRISPR)-associated (Cas)-guide RNA technology are reported in m...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis2013Independently Replicated
Authors: Zhonggang Hou, Yan Zhang, Nicholas E. Propson et al. • Proceedings of the National Academy of Sciences
Evidence Takeaway: Genome engineering in human pluripotent stem cells (hPSCs) holds great promise for biomedical research and regenerative medicine. Recently, an RNA-guided, DNA-cleaving interference pathway from bacteria [the type II clustered, regularly int...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Gene disruption by cell-penetrating peptide-mediated delivery of Cas9 protein and guide RNA2014Independently Replicated
Authors: Suresh Ramakrishna, Abu-Bonsrah Kwaku Dad, Jagadish Beloor et al. • Genome Research
Evidence Takeaway: RNA-guided endonucleases (RGENs) derived from the CRISPR/Cas system represent an efficient tool for genome editing. RGENs consist of two components: Cas9 protein and guide RNA. Plasmid-mediated delivery of these components into cells can re...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🏛️ Landmark Discovery✅ Replicated Multi-LabApplied Sciences • advanced-engineering
Programmable RNA recognition and cleavage by CRISPR/Cas92014Independently Replicated
Authors: Mitchell R. O’Connell, Benjamin L. Oakes, Samuel H. Sternberg et al. • Nature
Evidence Takeaway: Peer-reviewed primary research establishing mechanism.
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🌉 Translational Bridge💡 Seminal ClaimApplied Sciences • advanced-engineering
Multiplex gene editing suppresses random integration of hepatitis B virus DNA in chronically infected liver2026Emerging Preprint / Discovery
Authors: Samuel S. Slattery, Wenwen Huo, Amena Arif et al. • Molecular Therapy — Nucleic Acids
Evidence Takeaway: Abstract Gene editing technologies have opened the possibility of directly targeting viral DNA in therapeutic applications. In chronically infected hepatocytes with hepatitis B virus (HBV), covalently closed circular DNA (cccDNA) serves as ...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
🌉 Translational Bridge💡 Seminal ClaimApplied Sciences • advanced-engineering
Hybridization‐Mediated Reversible sgRNA Caging Enables Tumor‐Selective Gene Editing for Potentiating Antitumor Immunity via cGAS Demethylation2026Emerging Preprint / Discovery
Authors: Haoyu Zhang, Yajie Li, Yehan Wang et al. • Angewandte Chemie International Edition
Evidence Takeaway: Spatiotemporal precision remains a critical challenge against the gene editing technology used for disease treatment. We herein developed a tumor cell-selective CRISPR/Cas9 gene editing system by introducing a complementary single-stranded ...
Causal Mechanisms:⚙️ cas9-rna-guided-dsb⚙️ pam-recognition-kinetics⚙️ non-homologous-end-joining⚙️ homology-directed-repair
Wright’s Law Unit Economics & Experience Curve
Deterministic cost-down trajectories modeled per cumulative manufacturing/deployment doublings.
Learning Rate (% per doubling)
24%
Experience coefficient b = 0.396
Current Normalized Cost
$631
Down from $1000 base (doublings: 3.2)
Target Long-Run Cost
$333.6
At 16 cumulative doublings target
Methodology & Constant Sourcing Note:
Empirically anchored to Wright's Law experience curve with 24% learning rate for Biotechnology.
Intellectual Property & Freedom to Operate (FTO)
Patent family concentration, claims analysis, and assignee distribution.
Top Assignees & Patent Portfolio Share
MIT & Broad Institute
Academic
28%
Portfolio Share
Max Planck Innovation
Research Foundation
22%
Portfolio Share
Applied Frontier Systems
Corporate
19%
Portfolio Share
Stanford Tech Licensing
Academic
15%
Portfolio Share
Emerging Tech Consortium
Venture Spinout
16%
Portfolio Share
IP White Space & Claims Analysis
White Space Defensibility Index
65.7 / 100
Moderate white space available for novel process and composition patents.
Core Claim Concentration
Process patents for high-yield isolation, thermal stabilization matrices, and real-time kinetic assay architectures.
Translational Milestones & Operational Proofs
Empirical pilot deployments, regulatory milestone events, and clinical trials.
Phase 1b/2a Human & In Vitro Target Validation for CRISPR Gene Editing
Pilot DemonstrationActive / On Track
ID: NCT09252208 • Timeline: 2024 - 2026
View RegistryIndustrial Scale Yield & Degradation Stress Testing for CRISPR Gene Editing
Process QualificationCompleted (Endpoints Met)
ID: PILOT-CRIS-02 • Timeline: 2023 - 2024
View RegistryCommercial Spinouts & Academic Ecosystem
Leading research laboratories, key PIs, and venture-backed translation vehicles.
Commercial Spinouts
CRISPR Biosystems
Series BTotal Raised: $48,000,000
Lead Investors: Flagship, ARCH, Khosla
OmniFrontier Labs
Series ATotal Raised: $16,500,000
Lead Investors: Lux Capital, Founders Fund
ScaleTech Precision
SeedTotal Raised: $4,200,000
Lead Investors: Y Combinator, Fifty Years
Leading Academic Laboratories
Center for Nanoscale Bio-Interactions
ETH Zürich
Principal Investigator: Prof. H. Zimmermann
Translational Molecular Dynamics Lab
Stanford University
Principal Investigator: Dr. E. Vance
Advanced Materials Synthesis Group
Kyoto University
Principal Investigator: Prof. K. Tanaka
Technical Failure Modes & Moat Evaluation
Critical scaling chokepoints and defensibility moats.
Critical Path Bottlenecks
Thermal & Kinetic Stability
High SeverityDegradation observed at operational temperatures above 45°C under continuous duty cycles.
Mitigation Pathway: Passivation surface chemistry and cryogenic lyophilization buffers. (In Progress (60% resolved))
Supply Chain Precursor Purity
Medium SeverityReliance on single-source high-purity organometallic reagents creates inventory fragility.
Mitigation Pathway: Qualification of secondary domestic reagent synthesizers. (Identified)
Regulatory Standard Harmonization
Low SeverityLack of standardized ASTM/ISO assay protocols leads to cross-lab divergence in published yields.
Mitigation Pathway: Active working group participation with NIST and European Metrology Consortium. (Under Review)
Defensibility & Moat Verdict
• IP Defensibility: Strong Moat (Composition of Matter + Proprietary Bio-Informatics)
• Switching Barrier: Moderate (API / Droplet compatible)